298 related articles for article (PubMed ID: 30031971)
1. Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities.
Knez D; Coquelle N; Pišlar A; Žakelj S; Jukič M; Sova M; Mravljak J; Nachon F; Brazzolotto X; Kos J; Colletier JP; Gobec S
Eur J Med Chem; 2018 Aug; 156():598-617. PubMed ID: 30031971
[TBL] [Abstract][Full Text] [Related]
2. Biological Evaluation of 8-Hydroxyquinolines as Multi-Target Directed Ligands for Treating Alzheimer's Disease.
Knez D; Sosič I; Pišlar A; Mitrović A; Jukič M; Kos J; Gobec S
Curr Alzheimer Res; 2019; 16(9):801-814. PubMed ID: 31660830
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease.
Gutti G; Kakarla R; Kumar D; Beohar M; Ganeshpurkar A; Kumar A; Krishnamurthy S; Singh SK
Eur J Med Chem; 2019 Nov; 182():111613. PubMed ID: 31437780
[TBL] [Abstract][Full Text] [Related]
4. Development of naringenin-O-carbamate derivatives as multi-target-directed liagnds for the treatment of Alzheimer's disease.
Mi J; He Y; Yang J; Zhou Y; Zhu G; Wu A; Liu W; Sang Z
Bioorg Med Chem Lett; 2022 Mar; 60():128574. PubMed ID: 35065231
[TBL] [Abstract][Full Text] [Related]
5. Novel salicylamide derivatives as potent multifunctional agents for the treatment of Alzheimer's disease: Design, synthesis and biological evaluation.
Song Q; Li Y; Cao Z; Qiang X; Tan Z; Deng Y
Bioorg Chem; 2019 Mar; 84():137-149. PubMed ID: 30500523
[TBL] [Abstract][Full Text] [Related]
6. Search for new multi-target compounds against Alzheimer's disease among histamine H
Bajda M; Łażewska D; Godyń J; Zaręba P; Kuder K; Hagenow S; Łątka K; Stawarska E; Stark H; Kieć-Kononowicz K; Malawska B
Eur J Med Chem; 2020 Jan; 185():111785. PubMed ID: 31669851
[TBL] [Abstract][Full Text] [Related]
7. 1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer's disease.
Wichur T; Więckowska A; Więckowski K; Godyń J; Jończyk J; Valdivieso ÁDR; Panek D; Pasieka A; Sabaté R; Knez D; Gobec S; Malawska B
Eur J Med Chem; 2020 Feb; 187():111916. PubMed ID: 31812794
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and evaluation of cinnamic acid hybrids as multi-target-directed agents for the treatment of Alzheimer's disease.
Wang K; Shi J; Zhou Y; He Y; Mi J; Yang J; Liu S; Tang X; Liu W; Tan Z; Sang Z
Bioorg Chem; 2021 Jul; 112():104879. PubMed ID: 33915461
[TBL] [Abstract][Full Text] [Related]
9. N-alkylpiperidine carbamates as potential anti-Alzheimer's agents.
Košak U; Strašek N; Knez D; Jukič M; Žakelj S; Zahirović A; Pišlar A; Brazzolotto X; Nachon F; Kos J; Gobec S
Eur J Med Chem; 2020 Jul; 197():112282. PubMed ID: 32380361
[TBL] [Abstract][Full Text] [Related]
10. Development of cyanopyridine-triazine hybrids as lead multitarget anti-Alzheimer agents.
Maqbool M; Manral A; Jameel E; Kumar J; Saini V; Shandilya A; Tiwari M; Hoda N; Jayaram B
Bioorg Med Chem; 2016 Jun; 24(12):2777-88. PubMed ID: 27157006
[TBL] [Abstract][Full Text] [Related]
11. Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease.
Bai P; Wang K; Zhang P; Shi J; Cheng X; Zhang Q; Zheng C; Cheng Y; Yang J; Lu X; Sang Z
Eur J Med Chem; 2019 Dec; 183():111737. PubMed ID: 31581002
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of novel (4-(1,2,4-oxadiazol-5-yl)phenyl)-2-aminoacetamide derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Liu T; Chen S; Du J; Xing S; Li R; Li Z
Eur J Med Chem; 2022 Jan; 227():113973. PubMed ID: 34752955
[TBL] [Abstract][Full Text] [Related]
13. N-Propargylpiperidines with naphthalene-2-carboxamide or naphthalene-2-sulfonamide moieties: Potential multifunctional anti-Alzheimer's agents.
Košak U; Knez D; Coquelle N; Brus B; Pišlar A; Nachon F; Brazzolotto X; Kos J; Colletier JP; Gobec S
Bioorg Med Chem; 2017 Jan; 25(2):633-645. PubMed ID: 27908752
[TBL] [Abstract][Full Text] [Related]
14. Chromone-lipoic acid conjugate: Neuroprotective agent having acceptable butyrylcholinesterase inhibition, antioxidant and copper-chelation activities.
Jalili-Baleh L; Nadri H; Forootanfar H; Küçükkılınç TT; Ayazgök B; Sharifzadeh M; Rahimifard M; Baeeri M; Abdollahi M; Foroumadi A; Khoobi M
Daru; 2021 Jun; 29(1):23-38. PubMed ID: 33420969
[TBL] [Abstract][Full Text] [Related]
15. The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer's disease.
Sang Z; Wang K; Shi J; Liu W; Cheng X; Zhu G; Wang Y; Zhao Y; Qiao Z; Wu A; Tan Z
Eur J Med Chem; 2020 Apr; 192():112180. PubMed ID: 32131034
[TBL] [Abstract][Full Text] [Related]
16. Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease.
Jeřábek J; Uliassi E; Guidotti L; Korábečný J; Soukup O; Sepsova V; Hrabinova M; Kuča K; Bartolini M; Peña-Altamira LE; Petralla S; Monti B; Roberti M; Bolognesi ML
Eur J Med Chem; 2017 Feb; 127():250-262. PubMed ID: 28064079
[TBL] [Abstract][Full Text] [Related]
17. Apigenin-rivastigmine hybrids as multi-target-directed liagnds for the treatment of Alzheimer's disease.
Sang Z; Wang K; Shi J; Cheng X; Zhu G; Wei R; Ma Q; Yu L; Zhao Y; Tan Z; Liu W
Eur J Med Chem; 2020 Feb; 187():111958. PubMed ID: 31865014
[TBL] [Abstract][Full Text] [Related]
18. Serotonin 5-HT
Więckowski K; Szałaj N; Gryzło B; Wichur T; Góral I; Sługocka E; Sniecikowska J; Latacz G; Siwek A; Godyń J; Bucki A; Kołaczkowski M; Więckowska A
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012707
[TBL] [Abstract][Full Text] [Related]
19. Development of genistein-O-alkylamines derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Sang Z; Shi J; Zhou Y; Wang K; Zhao Y; Li Q; Qiao Z; Wu A; Tan Z; Liu W
Bioorg Chem; 2021 Feb; 107():104602. PubMed ID: 33453647
[TBL] [Abstract][Full Text] [Related]
20. Selective Pseudo-irreversible Butyrylcholinesterase Inhibitors Transferring Antioxidant Moieties to the Enzyme Show Pronounced Neuroprotective Efficacy In Vitro and In Vivo in an Alzheimer's Disease Mouse Model.
Scheiner M; Hoffmann M; He F; Poeta E; Chatonnet A; Monti B; Maurice T; Decker M
J Med Chem; 2021 Jul; 64(13):9302-9320. PubMed ID: 34152756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
